These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study. Auchus RJ; Courtillot C; Dobs A; El-Maouche D; Falhammar H; Lacroix A; Farrar M; O'Donoghue C; Anatchkova M; Cutts K; Taylor N; Yonan C; Lamotte M; Touraine P Front Endocrinol (Lausanne); 2022; 13():1005963. PubMed ID: 36465641 [TBL] [Abstract][Full Text] [Related]
11. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue. Halper A; Sanchez B; Hodges JS; Dengel DR; Petryk A; Sarafoglou K Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802 [TBL] [Abstract][Full Text] [Related]
12. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia. Schernthaner-Reiter MH; Baumgartner-Parzer S; Egarter HC; Krebs M; Kautzky-Willer A; Kirchheiner K; Luger A; Bayerle-Eder M J Sex Med; 2019 Oct; 16(10):1529-1540. PubMed ID: 31447379 [TBL] [Abstract][Full Text] [Related]
13. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion. Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370 [TBL] [Abstract][Full Text] [Related]
14. Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia. Liu SC; Suresh M; Jaber M; Mercado Munoz Y; Sarafoglou K Front Endocrinol (Lausanne); 2023; 14():1101843. PubMed ID: 36936152 [TBL] [Abstract][Full Text] [Related]
15. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056 [TBL] [Abstract][Full Text] [Related]
16. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth? Logan LA; Nebesio TD; Eckert GJ; Eugster EA Horm Res Paediatr; 2022; 95(5):461-464. PubMed ID: 35649383 [TBL] [Abstract][Full Text] [Related]
17. Quantitative targeted GC-MS-based urinary steroid metabolome analysis for treatment monitoring of adolescents and young adults with autoimmune primary adrenal insufficiency. Kamrath C; Hartmann MF; Wudy SA Steroids; 2019 Oct; 150():108426. PubMed ID: 31228484 [TBL] [Abstract][Full Text] [Related]
18. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia. Ünal S; Alikaşifoğlu A; Özön A; Gönç N; Kandemir N Turk J Pediatr; 2020; 62(3):359-366. PubMed ID: 32558409 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty. Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958 [TBL] [Abstract][Full Text] [Related]